Back to Search Start Over

Identification of environmental factors that promote intestinal inflammation.

Authors :
Sanmarco LM
Chao CC
Wang YC
Kenison JE
Li Z
Rone JM
Rejano-Gordillo CM
Polonio CM
Gutierrez-Vazquez C
Piester G
Plasencia A
Li L
Giovannoni F
Lee HG
Faust Akl C
Wheeler MA
Mascanfroni I
Jaronen M
Alsuwailm M
Hewson P
Yeste A
Andersen BM
Franks DG
Huang CJ
Ekwudo M
Tjon EC
Rothhammer V
Takenaka M
de Lima KA
Linnerbauer M
Guo L
Covacu R
Queva H
Fonseca-Castro PH
Bladi MA
Cox LM
Hodgetts KJ
Hahn ME
Mildner A
Korzenik J
Hauser R
Snapper SB
Quintana FJ
Source :
Nature [Nature] 2022 Nov; Vol. 611 (7937), pp. 801-809. Date of Electronic Publication: 2022 Oct 20.
Publication Year :
2022

Abstract

Genome-wide association studies have identified risk loci linked to inflammatory bowel disease (IBD) <superscript>1</superscript> -a complex chronic inflammatory disorder of the gastrointestinal tract. The increasing prevalence of IBD in industrialized countries and the augmented disease risk observed in migrants who move into areas of higher disease prevalence suggest that environmental factors are also important determinants of IBD susceptibility and severity <superscript>2</superscript> . However, the identification of environmental factors relevant to IBD and the mechanisms by which they influence disease has been hampered by the lack of platforms for their systematic investigation. Here we describe an integrated systems approach, combining publicly available databases, zebrafish chemical screens, machine learning and mouse preclinical models to identify environmental factors that control intestinal inflammation. This approach established that the herbicide propyzamide increases inflammation in the small and large intestine. Moreover, we show that an AHR-NF-κB-C/EBPβ signalling axis operates in T cells and dendritic cells to promote intestinal inflammation, and is targeted by propyzamide. In conclusion, we developed a pipeline for the identification of environmental factors and mechanisms of pathogenesis in IBD and, potentially, other inflammatory diseases.<br /> (© 2022. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
1476-4687
Volume :
611
Issue :
7937
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
36266581
Full Text :
https://doi.org/10.1038/s41586-022-05308-6